Massimo Sabatini

1.3k total citations
28 papers, 1.0k citations indexed

About

Massimo Sabatini is a scholar working on Oncology, Rheumatology and Molecular Biology. According to data from OpenAlex, Massimo Sabatini has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Rheumatology and 7 papers in Molecular Biology. Recurrent topics in Massimo Sabatini's work include Osteoarthritis Treatment and Mechanisms (13 papers), Protease and Inhibitor Mechanisms (7 papers) and Bone health and treatments (6 papers). Massimo Sabatini is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (13 papers), Protease and Inhibitor Mechanisms (7 papers) and Bone health and treatments (6 papers). Massimo Sabatini collaborates with scholars based in France, Italy and Australia. Massimo Sabatini's co-authors include Philippe Pastoureau, Christophe Lesur, Frédéric De Ceuninck, Brian G.M. Durie, Donald R. Bertolini, Gregory R. Mundy, Timothy S. Bringman, Alison Gillespie, Glenn E. Nedwin and I. Ross Garrett and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Massimo Sabatini

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Sabatini France 16 415 342 234 164 137 28 1.0k
Lindsay Coleman United Kingdom 12 733 1.8× 274 0.8× 174 0.7× 159 1.0× 198 1.4× 17 1.4k
Hans‐Georg Wisniewski United States 22 724 1.7× 201 0.6× 263 1.1× 97 0.6× 165 1.2× 33 1.8k
Charles R. Hanning United States 12 778 1.9× 319 0.9× 307 1.3× 50 0.3× 294 2.1× 12 1.4k
Zhenqi Shi United States 14 944 2.3× 459 1.3× 220 0.9× 41 0.3× 179 1.3× 22 1.6k
Alexis Grande Italy 25 824 2.0× 310 0.9× 112 0.5× 280 1.7× 132 1.0× 70 1.6k
Tania M. Schroeder United States 10 1.2k 2.9× 400 1.2× 145 0.6× 87 0.5× 215 1.6× 11 1.7k
Maria Ziółkowska Poland 9 275 0.7× 221 0.6× 362 1.5× 139 0.8× 80 0.6× 16 988
Yasuto Araki Japan 15 590 1.4× 298 0.9× 253 1.1× 100 0.6× 163 1.2× 31 1.4k
Yang Du China 14 816 2.0× 188 0.5× 97 0.4× 84 0.5× 220 1.6× 33 1.2k
Adam P. Cribbs United Kingdom 20 687 1.7× 189 0.6× 184 0.8× 87 0.5× 189 1.4× 58 1.4k

Countries citing papers authored by Massimo Sabatini

Since Specialization
Citations

This map shows the geographic impact of Massimo Sabatini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Sabatini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Sabatini more than expected).

Fields of papers citing papers by Massimo Sabatini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Sabatini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Sabatini. The network helps show where Massimo Sabatini may publish in the future.

Co-authorship network of co-authors of Massimo Sabatini

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Sabatini. A scholar is included among the top collaborators of Massimo Sabatini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Sabatini. Massimo Sabatini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Letarouilly, Jean-Guillaume, Thomas Levin Andersen, Tanja Sikjær, et al.. (2021). Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss. PLoS ONE. 16(1). e0245014–e0245014. 17 indexed citations
2.
Rueda, Patricia, et al.. (2017). G protein-coupled receptors as anabolic drug targets in osteoporosis. Pharmacology & Therapeutics. 184. 1–12. 15 indexed citations
3.
Volpe, Roberto, et al.. (2017). Hypertriglyceridemia, an Underestimated Cardiovascular Risk Factor: An Epidemiological Study of the Rome Area. High Blood Pressure & Cardiovascular Prevention. 24(4). 401–404. 3 indexed citations
5.
Ceuninck, Frédéric De, Massimo Sabatini, & Philippe Pastoureau. (2011). Recent progress toward biomarker identification in osteoarthritis. Drug Discovery Today. 16(9-10). 443–449. 33 indexed citations
6.
Carnevale, Vincenzo, et al.. (2010). Estimate of renal function in oldest old inpatients by MDRD study equation, Mayo Clinic equation and creatinine clearance. Journal of Nephrology. 23(3). 306–313. 12 indexed citations
7.
Vidal, Aurélien, et al.. (2007). Synthesis and in vitro evaluation of targeted tetracycline derivatives: Effects on inhibition of matrix metalloproteinases. Bioorganic & Medicinal Chemistry. 15(6). 2368–2374. 20 indexed citations
8.
Sabatini, Massimo, et al.. (2006). A microplate assay for the screening of ADAMTS-4 inhibitors. Matrix Biology. 25(4). 261–267. 5 indexed citations
9.
Sabatini, Massimo, Christophe Lesur, Agnès Chomel, et al.. (2005). Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis. Arthritis & Rheumatism. 52(1). 171–180. 68 indexed citations
10.
Sabatini, Massimo, Philippe Pastoureau, & Frédéric De Ceuninck. (2004). Cellular and molecular tools. Humana Press eBooks. 4 indexed citations
11.
Ceuninck, Frédéric De, Massimo Sabatini, & Philippe Pastoureau. (2004). Structure and in vivo analysis. Humana Press eBooks. 3 indexed citations
12.
Ceuninck, Frédéric De, et al.. (2004). Culture of Chondrocytes in Alginate Beads. Humana Press eBooks. 100. 15–22. 43 indexed citations
13.
Lesur, Christophe & Massimo Sabatini. (2004). Assays of Proteoglycan and Collagen Degradation in Cultures of Rabbit Cartilage Explants. Humana Press eBooks. 100. 219–236. 2 indexed citations
14.
Pellecchia, Maria Teresa, Carmine Vitale, Massimo Sabatini, et al.. (2004). Ropinirole as a Treatment of Restless Legs Syndrome in Patients on Chronic Hemodialysis. Clinical Neuropharmacology. 27(4). 178–181. 63 indexed citations
15.
Diguarher, Thierry Le, Nathalie Kucharczyk, Marc Bertrand, et al.. (2002). Solid-phase synthesis of α-substituted 3-bisarylthio N-Hydroxy propionamides as Specific MMP Inhibitors. Bioorganic & Medicinal Chemistry. 10(3). 531–544. 22 indexed citations
16.
Sabatini, Massimo, et al.. (2001). Effects of Ceramide on Aggrecanase Activity in Rabbit Articular Cartilage. Biochemical and Biophysical Research Communications. 283(5). 1105–1110. 11 indexed citations
17.
Diguarher, Thierry Le, Marc Bertrand, Gordon C. Tucker, et al.. (2001). General synthesis of α-substituted 3-bisaryloxy propionic acid derivatives as specific mmp inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(3). 295–299. 13 indexed citations
18.
Sabatini, Massimo, Gaëlle Rolland, Stéphane Léonce, et al.. (2000). Effects of Ceramide on Apoptosis, Proteoglycan Degradation, and Matrix Metalloproteinase Expression in Rabbit Articular Cartilage. Biochemical and Biophysical Research Communications. 267(1). 438–444. 55 indexed citations
19.
Sabatini, Massimo, et al.. (1990). Bone Invasion by Walker 256 Carcinoma, Line A in Young and Adult Rats: Effects of Etidronate. Oncology. 47(2). 160–165. 13 indexed citations
20.
Guaitani, A., et al.. (1985). An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1-bis(phosphonate).. PubMed. 45(5). 2206–9. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026